{"release":"wpf-claim-checks","version":"1.6.0","checkedOn":"2026-11-15","verificationLabel":"AI-assisted source verification","humanReview":"none recorded","claim":{"id":"bpc-157-human-safety","claimWording":"BPC-157 has been shown to be safe in people.","wordingKind":"representative","quoted":null,"title":"BPC-157 and safety in humans","peptides":["bpc-157"],"aliases":["BPC 157","Body Protection Compound-157","Bepecin"],"topics":["safety"],"verdict":"insufficient_evidence","plainAnswer":"WPF found only very small human reports: a two-person intravenous pilot with no adverse effects reported, and a retrospective knee-pain series that reported pain outcomes rather than safety data. That cannot show safety, and the one registered safety trial has no posted results.","scope":{"population":"Humans: two adults in an intravenous pilot; 16 patients followed in a retrospective knee-pain series (12 of them treated with BPC-157 alone); a registered phase 1 trial with no posted results","design":"Uncontrolled pilot and retrospective case series; a registered phase 1 trial with no posted results","boundary":"Short-term tolerability in the reported people. This check does not assess long-term, repeated-dose, injectable-product-quality or interaction risks."},"strongest":[{"label":"Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (Altern Ther Health Med, 2025; PMID 40131143)","url":"https://pubmed.ncbi.nlm.nih.gov/40131143/","kind":"Peer-reviewed paper","population":"2 healthy adults (58 and 68 years old) at one private clinic, each previously exposed to BPC-157","design":"Uncontrolled pilot: intravenous infusions on two consecutive days, with blood work before and after","locator":"Abstract, Participants and Results: no measurable effects on the tested heart, liver, kidney, thyroid and glucose markers; no side effects reported. The authors conclude that the study \"showed the safety of BPC-157 in humans\"; this check does not accept that conclusion from two participants."},{"label":"Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain (Altern Ther Health Med, 2021; 27(4):8-13; PMID 34324435)","url":"https://pubmed.ncbi.nlm.nih.gov/34324435/","kind":"Peer-reviewed paper","population":"Adults with knee pain from several causes at one clinic: 17 patients in the chart review, 16 reached by telephone, 12 of them treated with BPC-157 alone","design":"Retrospective, uncontrolled case series (chart review and telephone follow-up). It assessed knee pain, not safety","locator":"Abstract, Methods and Results: patients rated their own pain and the benefit; the abstract reports improvement outcomes and no adverse-event data. Abstract only: WPF did not read the full text."},{"label":"Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (HSS J, 2025; PMID 40756949; PMC12313605)","url":"https://pubmed.ncbi.nlm.nih.gov/40756949/","kind":"Systematic review","population":"36 studies: 35 preclinical, 1 clinical (the knee-pain case series above, reported as 12 patients)","design":"Systematic review of English-language literature to 3 June 2024; the clinical study was retrospective","locator":"Abstract, Results: \"No clinical safety data were found.\" The single clinical study is a retrospective report of intra-articular injection for chronic knee pain (Results text beginning \"Only 1 clinical study could be identified\")."},{"label":"PCO-02 safety and pharmacokinetics trial (NCT02637284)","url":"https://clinicaltrials.gov/study/NCT02637284","kind":"Registry record","population":"42 participants planned (estimated)","design":"Registered phase 1 randomized, placebo-controlled trial of an oral formulation (intervention name Bepecin)","locator":"Record header: status Unknown, last verified 2015-10; no results posted."}],"uncertain":["Two people cannot detect uncommon adverse events, and neither report was randomized or blinded.","The knee-pain series is uncontrolled, rests on patients' own reports and does not report safety outcomes in its abstract.","No long-term, repeated-dose or product-purity data were found. Products sold as research chemicals may differ from what was tested.","A registered trial with unknown status and no results gives no safety information."],"wouldChange":["Posted or published results from a registered, controlled human safety trial with a defined adverse-event follow-up.","Independent analysis of what products labelled BPC-157 actually contain."],"gaps":["No controlled human safety data were found. WPF did not search adverse-event reporting systems, so reports there, or their absence, are not assessed. The full text of the knee-pain series was not read."],"searchScope":{"searchedOn":"2026-11-15","sources":["PubMed","ClinicalTrials.gov API v2"],"queries":["PubMed: BPC-157 / BPC 157 in title or abstract -> 230 records, read for human studies by title and the 2025 systematic review's abstract","ClinicalTrials.gov: query.intr=BPC-157 -> 4 interventional registrations, none with posted results (NCT07803250, NCT07437547, NCT02637284, NCT07752381; the other three are efficacy, muscle-strain and supplement studies, see the tendon-healing check)"],"found":"Two small human reports, one uncontrolled knee-pain series and one registered phase 1 trial with unknown status.","notSearched":["FDA adverse event reporting (FAERS) and other pharmacovigilance databases","Poison-control and clinic records","Full text of the 230 PubMed records"]},"regulatory":null,"checkedOn":"2026-11-15","links":{"profiles":["/directory/bpc-157"],"films":["/films/repair-recovery/bpc-157"],"flagship":[],"journeys":[],"teaching":[],"changes":[]},"extends1_0_0":false},"sha256":"d6a7d1d0f1a031720550053d118fdd6830f28e3f6fcd5b5a77859e7448e5c735"}